|
EducationUSA Malaysia 2026-2027
|
U.S. Mission to Malaysia |
July 31, 2026
1d left
|
$224k |
Nonprofits
|
|
Empowering English Educators
|
U.S. Mission to Egypt |
August 7, 2026
8d left
|
$200k |
Nonprofits
|
|
English Language Fellows Program
|
U.S. Mission to Egypt |
August 7, 2026
8d left
|
$480k |
Nonprofits
|
|
Mentor Program for English Educators
|
U.S. Mission to Egypt |
August 9, 2026
10d left
|
$150k |
Nonprofits
|
|
Freedom250 Advancing U.S. Artificial Intelligence Leadership in Algeria
|
U.S. Mission to Algeria |
August 10, 2026
11d left
|
$30k |
Nonprofits
Individuals
|
|
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
|
National Institutes of Health |
August 18, 2026
19d left
|
— |
Nonprofits
|
|
Access Alumni Outreach and Engagement and English Access Scholarship Program
|
U.S. Mission to Kazakhstan |
August 21, 2026
22d left
|
$50k |
Nonprofits
|
|
Building Skills, Strengthening Communities, and Advancing Innovation in Northwest Mexico
|
U.S. Mission to Mexico |
August 27, 2026
28d left
|
$20k |
Nonprofits
|
|
Annual Program Statement for Public Diplomacy Section Fiscal Year 2026
|
U.S. Mission to Cambodia |
August 30, 2026
31d left
|
$25k |
Nonprofits
|
|
Brookwood-Sago Mine Safety Grants
|
Mine Safety and Health Administration |
August 31, 2026
32d left
|
$250k |
Nonprofits
|
|
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 7, 2026
39d left
|
$499k |
Nonprofits
|
|
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 7, 2026
39d left
|
— |
Nonprofits
|
|
Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
|
National Institutes of Health |
September 7, 2026
39d left
|
— |
Nonprofits
|
|
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
|
National Institutes of Health |
September 25, 2026
|
— |
Nonprofits
|
|
National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 28, 2026
|
$400k |
Nonprofits
|
|
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
|
National Institutes of Health |
September 28, 2026
|
— |
Nonprofits
|
|
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
|
National Institutes of Health |
September 28, 2026
|
— |
Nonprofits
|
|
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
|
National Institutes of Health |
October 14, 2026
|
— |
Nonprofits
|
|
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
|
National Institutes of Health |
October 14, 2026
|
— |
Nonprofits
|
|
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 14, 2026
|
— |
Nonprofits
|
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
|
National Institutes of Health |
October 14, 2026
|
$250k |
Nonprofits
|
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 14, 2026
|
— |
Nonprofits
|
|
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
|
National Institutes of Health |
October 30, 2026
|
— |
Nonprofits
|
|
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 5, 2026
|
— |
Nonprofits
|
|
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 6, 2026
|
$350k |
Nonprofits
|